Peptide research guides and blog
Deep, honest, research-use-only guides to every peptide in our range, plus comparisons and lab how-tos. Written for Australian researchers and backed by a verified Novagen Certificate of Analysis on every batch.
Peptide research guides
Is BPC-157 at Chemist Warehouse? (Australia 2026)
Can you buy BPC-157 at a retail pharmacy in Australia? A plain, factual look at its regulatory status and research-use supply. General information only, not legal or medical advice.
Read the guide →Unapproved Peptides and Safety in Australia
A neutral explainer on why unapproved peptides carry regulatory and quality uncertainty in Australia, and the research-use-only versus approved-medicine distinction. General information only, not legal or medical advice.
Read the guide →Peptide Purity Explained (Research Guide)
What purity means for a research peptide: HPLC chromatographic purity, mass spec identity, and net peptide content. General information only, not legal or medical advice.
Read the guide →Amycretin vs CagriSema: Research Compared
A neutral comparison of amycretin, a single-molecule GLP-1 and amylin agonist, and CagriSema, a cagrilintide plus semaglutide co-formulation, by mechanism and development stage. General information only, not legal or medical advice.
Read the guide →Ipamorelin vs Sermorelin: Research Compared
A neutral comparison of ipamorelin, a ghrelin receptor agonist, and sermorelin, a GHRH analogue, by mechanism and research evidence stage. General information only, not legal or medical advice.
Read the guide →Is Sermorelin Legal in Australia? What to Know
A neutral look at how sermorelin, a GHRH analogue, sits under the Australian Poisons Standard, the ARTG and WADA anti-doping rules. General information only, not legal or medical advice.
Read the guide →Is AOD-9604 Legal in Australia? (2026)
A neutral look at how AOD-9604 is treated under the Australian Poisons Standard, the ARTG and WADA anti-doping rules. General information only, not legal or medical advice.
Read the guide →Peptide Stacking Explained (Research Guide)
A neutral guide to what stacking means in peptide study design, covering additive versus synergistic effects and the Australian regulatory context. General information only, not legal or medical advice.
Read the guide →NAD+ vs MOTS-c: Research Compared
A neutral comparison of NAD+ precursors and the mitochondrial peptide MOTS-c by mechanism and research evidence stage. General information only, not legal or medical advice.
Read the guide →Peptides for Libido in Australia (Research)
A neutral research overview of compounds studied in sexual-health literature, including PT-141 and kisspeptin, with Australian regulatory context. General information only, not legal or medical advice.
Read the guide →Is Ipamorelin Legal in Australia? What to Know
A neutral explainer on how ipamorelin is classified under Australian medicines law, including its Poisons Standard scheduling, ARTG and anti-doping status. General information only, not legal or medical advice.
Read the guide →Is CJC-1295 Legal in Australia? (2026)
A neutral explainer on how CJC-1295 is regulated in Australia, including its TGA, ARTG and anti-doping status. General information only, not legal or medical advice.
Read the guide →GLP-1 Pipeline 2026 in Australia (Research)
A neutral map of the next-wave metabolic research candidates by mechanism and trial stage, with Australian regulatory status noted for each. General information only, not legal or medical advice.
Read the guide →MariTide Australia: What the Research Shows
A neutral look at MariTide (maridebart cafraglutide), Amgen's investigational GIP-antagonist GLP-1-agonist candidate, and its research-use-only status in Australia. General information only, not legal or medical advice.
Read the guide →Peptides for Cognition in Australia (Research)
A neutral overview of peptide compounds that appear in cognition and neuroprotection research literature, with a plain look at their TGA and ARTG status in Australia. General information only, not legal or medical advice.
Read the guide →Bacteriostatic vs Sterile Water for Peptides
A neutral laboratory comparison of bacteriostatic water and sterile water as diluents for reconstituting research peptides. General information only, not legal or medical advice.
Read the guide →Is BPC-157 Legal in Australia? TGA Status Explained
A plain, neutral, factual look at the regulatory status of BPC-157 in Australia: how the TGA classifies it, what research use only means, and how that differs from an approved medicine. General information only, not legal or medical advice.
Read the guide →Where to Buy Research Peptides in Australia: Vetting Guide
Most pages give you a list of shops. This one gives you the criteria to judge any shop for yourself, then shows you how to check a certificate of analysis with your own eyes before you trust a single claim. General information only, not legal or medical advice.
Read the guide →Retatrutide Australia: TGA Status & Research Supply
A plain-English, research-use-only resource on retatrutide (LY3437943) for Australian researchers: its regulatory status, the triple-agonist science, what the TRIUMPH trials studied, and how it is supplied as the Retatrutide kit with an independent Novagen Certificate of Analysis.
Read the guide →Tirzepatide Australia: Research Guide
A clear, compliance-first look at tirzepatide australia research: what the compound is, how laboratories study it, its regulatory status, and how to source it with a verifiable Certificate of Analysis. Supplied strictly for laboratory and research use only.
Read the guide →Semaglutide Australia: Research Peptide Guide
A clear, factual overview of semaglutide, the GLP-1 receptor agonist studied widely in metabolic research. This page covers what it is, how it is studied, its Australian regulatory status, and how to source it for laboratory research use only.
Read the guide →MOTS-c Australia: Research Guide
A plain-English research reference for MOTS-c in Australia, covering what the peptide is, how it is studied in metabolic and endurance models, and how to source it for laboratory use from a transparent, COA-backed supplier.
Read the guide →NAD+ Australia: Research Guide & COA
A clear, compliance-first overview of NAD+ for Australian laboratory and research settings, covering what the coenzyme is, how it is studied, and how to source it with a verifiable certificate of analysis.
Read the guide →Ipamorelin Australia: Research Guide
A plain, evidence-led look at Ipamorelin for Australian researchers. What it is, how it is studied, the CJC-1295 context, reconstitution notes and what verified supply looks like.
Read the guide →CJC-1295 No DAC Australia: Research Guide
A plain-English reference on CJC-1295 (No DAC), the short-acting GHRH analogue widely studied alongside ipamorelin. Supplied strictly for laboratory and research use in Australia.
Read the guide →Semax Australia: Nootropic Peptide Guide
Semax is a short synthetic peptide studied for its proposed effects on focus, memory and neuroprotection in laboratory models. This guide covers what it is, how it is researched, its status in Australia, and what to look for in a transparent supplier.
Read the guide →Selank Australia: Research Guide
A clear, research-focused look at Selank, the synthetic anxiolytic peptide studied in stress and cognition models, and what Australian researchers should know before sourcing it.
Read the guide →HGH Australia: Research Guide & COA
A clear, compliance-first overview of human growth hormone for Australian laboratory contexts, including how it is measured in IU, why it is prescription-only, and how to source it with a verifiable Certificate of Analysis.
Read the guide →AOD-9604 Australia: Research Guide
A plain-English look at AOD-9604, a modified fragment of human growth hormone studied in fat-metabolism research, and what to check when sourcing it from a transparent Australian supplier.
Read the guide →Melanotan 2 Australia: Research Guide
A plain reference on Melanotan 2 for laboratory audiences in Australia. What MT-2 is, the melanocortin pathway it is studied against, its regulatory status, and what a transparent supplier and a verifiable COA look like.
Read the guide →Eli Lilly Tirzepatide Australia: Mounjaro
A factual look at how Eli Lilly's branded tirzepatide medicines compare with research grade tirzepatide supplied for laboratory use, and what the difference means in Australia.
Read the guide →HCG Australia: A Complete Research Guide
Human chorionic gonadotropin is one of the most closely mapped glycoprotein hormones in the literature, studied for the way it engages the luteinising hormone receptor across the hormonal axis. This guide covers what it is, how it works, and what it is investigated for. Supplied strictly for laboratory and research use only.
Read the guide →L-Carnitine Australia: The Research Guide
L-Carnitine is the amino-acid derivative at the centre of mitochondrial energy research, studied for its obligatory role in shuttling long-chain fatty acids into the mitochondria for beta-oxidation. This guide sets out what it is, the carnitine shuttle mechanism, the molecular targets involved and the research areas it appears in, written honestly for Australian researchers. NovaPeptides is Australian owned and Gold Coast based, has supplied research compounds to Australians for over three years, and ships every batch with a verified Novagen Certificate of Analysis. L-Carnitine is supplied strictly for laboratory and research use only and is not TGA approved for human use.
Read the guide →Lemon Bottle Australia: Lipolysis Research
Lemon Bottle is the multi-ingredient lipolysis solution that has become one of the most talked about compounds in localised fat-breakdown research, built around riboflavin, bromelain and lecithin and studied for how those components influence adipocyte membranes and triglyceride mobilisation in research models. This guide covers what it is, what the literature actually says and how it is handled in a laboratory context. NovaPeptides is Australian owned, based on the Gold Coast, and has supplied research compounds to Australians for over 3 years, with a verified Novagen Certificate of Analysis on every batch. Lemon Bottle is supplied strictly for laboratory and research use only and is not TGA approved for human use.
Read the guide →Delta Sleep-Inducing Peptide (DSIP) Australia
Delta sleep-inducing peptide, or DSIP, is a naturally occurring nonapeptide studied for its association with sleep architecture and the stress response. This guide covers what DSIP is, how it is investigated in the literature, and how NovaPeptides verifies every batch for Australian research.
Read the guide →ARA-290 (Cibinetide) Research Guide Australia
Inside erythropoietin sits a single active fragment that is studied for tissue repair without driving red blood cell production, and that fragment is ARA-290. This guide covers what it is, the receptor it targets, and what it is investigated for, all in a research context. Supplied by NovaPeptides for laboratory and research use only, with a verified Novagen Certificate of Analysis on every batch.
Read the guide →VIP (Vasoactive Intestinal Peptide) Australia
A reference guide to the 28-amino-acid neuropeptide studied for immune modulation, gut physiology and chronic inflammatory response research. Supplied in Australia for laboratory and research use only.
Read the guide →Thymosin Alpha-1 Australia Research Guide
Thymosin Alpha-1, also written Ta1 and known in the clinical literature as thymalfasin, is one of the most studied thymic peptides in immunology. It is a naturally occurring 28-amino-acid peptide produced by the thymus, where it helps direct the maturation of T lymphocytes, and in research it is examined as a broad immune-modulating signalling molecule that acts through Toll-like receptors rather than a single hormone receptor. This guide sets out what Thymosin Alpha-1 is, the receptor pathways and research areas attached to it, and how it is handled and verified in an Australian research context. NovaPeptides is Australian owned and Gold Coast based, has supplied research peptides to Australian researchers for over three years, and ships every batch with a verified Novagen Certificate of Analysis. It is supplied for laboratory and research use only and is not TGA approved for human use.
Read the guide →CJC-1295 + Ipamorelin Research Guide Australia
CJC-1295 (No DAC) and Ipamorelin is the classic GHRH-plus-secretagogue blend studied for pulsatile growth hormone release across two receptor pathways at once. This guide sets out what each component is, why the pair is researched together, and how NovaPeptides supplies it to Australian researchers with a verified Novagen Certificate of Analysis on every batch. It is written strictly as a research reference. The blend is not TGA approved and is supplied for laboratory and research use only.
Read the guide →GHRP-2 in Australia: The Research Peptide Guide
A reference guide to GHRP-2, the synthetic growth hormone secretagogue studied for its action at the ghrelin receptor and its role in growth hormone secretion. Written for a laboratory and research-use-only context in Australia.
Read the guide →GHRP-6 Peptide Australia: Research Overview
A plain-English reference on GHRP-6, a first-generation growth hormone secretagogue studied for its action at the ghrelin receptor, its effect on growth hormone secretion, and its role in appetite research. Supplied by NovaPeptides for laboratory and research use only, with a verified Novagen Certificate of Analysis on every batch.
Read the guide →Sermorelin Acetate Australia: GHRH (1-29) Guide
Sermorelin acetate is a synthetic GHRH (1-29) analogue studied for its role in the growth hormone axis. This is a plain-English, education-first guide for Australian researchers, written by an Australian-owned supplier that has served Australian researchers for over three years. It is not medical, dosing or clinical advice.
Read the guide →Matrixyl Australia: Pal-KTTKS Research Guide
Matrixyl, the palmitoylated pentapeptide Pal-KTTKS, is the matrikine that put collagen signalling on the map. This is a research reference on what it is, how it is thought to signal dermal fibroblasts, and what the published record actually shows. Supplied by NovaPeptides for laboratory research use only, with a verified Novagen Certificate of Analysis on every batch.
Read the guide →SNAP-8 Peptide Guide for Australian Research
A reference-grade overview of SNAP-8, the acetylated octapeptide studied for expression-line and neurocosmetic skin research. Supplied by NovaPeptides for laboratory and research use only, with a verified Novagen Certificate of Analysis on every batch.
Read the guide →Melanotan 1 (MT-1) Australia: Research Guide
A plain reference on Melanotan 1 for laboratory audiences in Australia. What MT-1 is, the melanocortin receptors it is studied against, how afamelanotide fits the picture, its regulatory status, and what a transparent supplier and a verifiable COA look like.
Read the guide →Epithalon Australia: Telomerase Research Guide
Epithalon, also written Epitalon and known by its amino acid sequence Ala-Glu-Asp-Gly (AEDG), is the tetrapeptide that longevity science keeps returning to. It is best known in the laboratory for its studied capacity to activate telomerase, the enzyme that maintains the telomere caps on chromosomes, and for a research history rooted in pineal gland and gerontology work. This guide sets out what Epithalon is, the molecular mechanisms researchers study, the shape of the evidence and where it is still thin, and how the compound is verified before it reaches an Australian laboratory. NovaPeptides is Australian owned and Gold Coast based, has supplied research peptides to Australians for over three years, and ships every batch with a verified Novagen Certificate of Analysis. Epithalon is supplied strictly for laboratory and research use only and is not TGA approved for human use.
Read the guide →5-Amino-1MQ Australia: NNMT Research Guide
A plain-English authority guide to 5-Amino-1MQ, the membrane-permeable NNMT inhibitor studied in NAD salvage and metabolic-ageing research. Supplied in Australia for laboratory and research use only, with a verified Novagen Certificate of Analysis on every batch.
Read the guide →Semax + Selank Australia | Research Nootropic Blend
A single reference for how Semax and Selank are studied together in cognitive and stress research, what receptor systems each one targets, and how the blend is handled in a laboratory setting. Supplied by NovaPeptides for research use only, with a verified Novagen Certificate of Analysis on every batch.
Read the guide →Kisspeptin Australia: Research Guide with COA
Kisspeptin is the signalling peptide named in study after study as the master switch of the reproductive-hormone axis, the upstream trigger for GnRH release. This guide covers the mechanism, the KISS1R receptor and the research landscape, and how NovaPeptides supplies it in Australia with a verified Novagen Certificate of Analysis on every batch.
Read the guide →B12 Australia: Methylcobalamin Research Guide
Vitamin B12, studied here as methylcobalamin, is the cobalt-containing cofactor that sits at the centre of how cells run energy metabolism and the methylation cycle. This guide covers what B12 is, its coenzyme forms and enzyme targets, and the research areas it appears in, with every batch supplied by NovaPeptides carrying a verified Novagen Certificate of Analysis for laboratory research use only.
Read the guide →Is Retatrutide Legal in Australia? (2026)
Retatrutide is an investigational compound that is not approved by the TGA and not listed on the ARTG. This page explains its regulatory status and what research use only means. General information only, not legal or medical advice.
Read the guide →Peptides for Weight Loss Australia: Category Guide
A neutral survey of the peptide compound classes that appear in fat-metabolism and energy-balance research literature, plus their Australian regulatory status. This hub links out to individual compound guides and covers science and law at a high level. General information only, not legal or medical advice.
Read the guide →CagriSema Australia: What It Is (2026)
A plain, neutral look at CagriSema, the investigational cagrilintide plus semaglutide combination, including its clinical trial stage and where it sits with Australian regulators as of 2026. General information only, not legal or medical advice.
Read the guide →Peptides for Recovery in Australia (Research Guide)
A neutral, academic look at the compounds that recovery and tissue-repair research literature has studied, including BPC-157, TB-500 and GHK-Cu, with their Australian regulatory status. All compounds are supplied strictly for laboratory research, not for human use. General information only, not legal or medical advice.
Read the guide →Cagrilintide Australia: Research Overview
A plain, factual look at cagrilintide (AM833), an investigational long-acting amylin analogue, covering its mechanism, research-literature context and Australian regulatory status. Supplied strictly for laboratory research use only. General information only, not legal or medical advice.
Read the guide →Peptides for Muscle Growth Australia: Research Guide
A conservative, educational overview of the growth-hormone-axis compounds that scientific literature groups under this heading, including their mechanism, research stage and Australian regulatory position. This page is a reference hub, not a product recommendation. General information only, not legal or medical advice.
Read the guide →Survodutide Australia: What the Research Shows
A neutral, factual explainer on survodutide (BI 456906), an investigational dual receptor agonist, covering its proposed mechanism, developers, clinical development stage and Australian regulatory status. General information only, not legal or medical advice.
Read the guide →Peptides for Anti-Ageing in Australia (Research)
A plain, factual look at the compounds commonly studied in ageing and longevity research, what they are, the pathways researchers examine, and where the evidence actually sits. All compounds discussed are supplied for laboratory research use only. General information only, not legal or medical advice.
Read the guide →Tesamorelin Australia: What the Research Shows
A plain, factual look at what Tesamorelin is, how it is described to act, and where it sits under Australian regulation and anti-doping rules. General information only, not legal or medical advice.
Read the guide →Peptide Reconstitution Calculator (AU Guide)
How the arithmetic of reconstituting a lyophilised research peptide works, concentration maths, water types and reading a U-100 syringe scale, written for laboratory handling of research-use-only materials. General information only, not legal or medical advice.
Read the guide →Orforglipron Australia: What It Is & TGA Status
A neutral, factual overview of orforglipron, an oral non-peptide small-molecule GLP-1 receptor agonist, covering its drug class, clinical trial programme, global regulatory status and its position in Australia. General information only, not legal or medical advice.
Read the guide →Amycretin Australia: Research Overview (2026)
A plain overview of amycretin, the single-molecule GLP-1 and amylin receptor agonist in clinical development by Novo Nordisk, how it differs from CagriSema, and its Australian regulatory position. Supplied by NovaPeptides strictly for laboratory research use only. General information only, not legal or medical advice.
Read the guide →Mazdutide Australia: Status, Mechanism and Facts
What mazdutide (IBI362 / LY3305677) is, how its dual receptor mechanism is described in the literature, and where it sits with regulators in China and Australia. Written for laboratory and educational context, supplied for research use only. General information only, not legal or medical advice.
Read the guide →Is Tirzepatide Legal in Australia? (2026 Guide)
A plain, factual look at how tirzepatide is regulated in Australia in 2026, covering its ARTG status, its place in the Poisons Standard, and how a registered prescription medicine differs from research-grade material supplied for laboratory use. General information only, not legal or medical advice.
Read the guide →PT-141 Australia: Research Overview (Bremelanotide)
A neutral, factual look at PT-141 (bremelanotide), the melanocortin receptor agonist peptide, including its mechanism, its regulatory position abroad and in Australia, and anti-doping context, framed strictly for laboratory research use. General information only, not legal or medical advice.
Read the guide →Pemvidutide Australia: Research Overview
A neutral, factual overview of pemvidutide (ALT-801), an investigational GLP-1 and glucagon dual receptor agonist, including its developer, mechanism, clinical trial stage and Australian regulatory status. Supplied by NovaPeptides strictly for laboratory research use only, not for human use. General information only, not legal or medical advice.
Read the guide →VK2735 Australia: What the Research Shows
A neutral, factual overview of VK2735, an investigational dual GIP and GLP-1 receptor agonist candidate from Viking Therapeutics, including its mechanism, development stage and Australian regulatory status. General information only, not legal or medical advice.
Read the guide →GHK-Cu Australia: Research Overview
A neutral, factual look at GHK-Cu, the copper tripeptide, covering its structure, the mechanisms studied in research, the state of the evidence and the Australian regulatory context. General information only, not legal or medical advice.
Read the guide →TB-500 Australia: Research Guide & Legal Status
A neutral, factual overview of TB-500 for Australian researchers: what the compound is, what the preclinical literature describes, and how it is classified under the Poisons Standard and in sport. General information only, not legal or medical advice.
Read the guide →SS-31 (Elamipretide) Australia: Research Overview
A neutral, factual overview of SS-31, also called elamipretide, covering its chemistry, the cardiolipin mechanism described in research, trial history, and Australian regulatory status. Supplied for laboratory research only. General information only, not legal or medical advice.
Read the guide →Is Semaglutide Legal in Australia? 2026 Guide
A plain factual explainer on how Australian regulators classify semaglutide in 2026, which approved products exist, and how that differs from research-grade supply. General information only, not legal or medical advice.
Read the guide →Peptides vs SARMs in Australia (Explained)
A plain, neutral look at how peptides and SARMs differ by structure, mechanism and Australian regulatory treatment, written for a research-use-only context. General information only, not legal or medical advice.
Read the guide →Peptides for Skin in Australia (Research Guide)
A goal based research hub explaining what skin and dermal study peptides are, the mechanisms examined in the literature, the quality of the evidence, and how Australia regulates cosmetic versus research grade compounds. General information only, not legal or medical advice.
Read the guide →Mounjaro vs Ozempic in Australia: Compared
A neutral look at how tirzepatide (Mounjaro) and semaglutide (Ozempic) differ by mechanism, and how each sits within Australian regulation including ARTG registration, Schedule 4 and the PBS. General information only, not legal or medical advice.
Read the guide →Wegovy vs Ozempic in Australia: Key Differences
A plain overview of how Wegovy and Ozempic, both semaglutide, differ by registered indication, dose range and PBS status in Australia. General information only, not legal or medical advice.
Read the guide →Is TB-500 Legal in Australia? Research Status
A neutral, conservative look at how TB-500, a synthetic peptide related to thymosin beta-4, is scheduled and regulated in Australia, written for a laboratory research-use-only context. General information only, not legal or medical advice.
Read the guide →Is PT-141 Legal in Australia? What to Know
A plain explainer of how PT-141, also known as bremelanotide, sits within Australian medicines law, the TGA Poisons Standard and the ARTG, written strictly for laboratory and research-use context. General information only, not legal or medical advice.
Read the guide →Peptides for Sleep in Australia: Research Hub
A neutral, goal-based summary of compounds studied in sleep and circadian research, written for laboratory and educational reference only. Human evidence is limited and no therapeutic claims are made. General information only, not legal or medical advice.
Read the guide →Peptides for Gut Health in Australia: Overview
A neutral look at peptides that have been investigated in gastrointestinal and gut-barrier research models, presented strictly for laboratory research context. General information only, not legal or medical advice.
Read the guide →Peptides for Longevity in Australia: Research Guide
A neutral overview of compounds studied in ageing and cellular-health research, written for research-use-only purposes. It makes no anti-ageing or efficacy claims and does not describe human use. General information only, not legal or medical advice.
Read the guide →BRP Peptide Australia: Research Overview (2026)
A neutral, factual overview of BRP (BRINP2-related peptide), an early-stage appetite-pathway discovery, its reported mechanism in animal models and its research-use-only status in Australia. General information only, not legal or medical advice.
Read the guide →Argireline Australia: Research Overview
A neutral, factual overview of Argireline (acetyl hexapeptide-8) for research reference: what it is, how its mechanism is described at the laboratory level, and how cosmetic ingredients sit within Australian regulation. General information only, not legal or medical advice.
Read the guide →Peptides for Hair Growth in Australia (Research)
A neutral overview of peptides that appear in hair-follicle and scalp research literature, written for research and educational context only. These are laboratory research compounds, not treatments, and nothing here describes outcomes in people. General information only, not legal or medical advice.
Read the guide →Is Melanotan-2 Legal in Australia? (2026)
A factual look at how Australia's Therapeutic Goods Administration treats Melanotan-2 (melanotan II), including its scheduling, its absence from the ARTG, and how it differs from the approved therapeutic good afamelanotide. General information only, not legal or medical advice.
Read the guide →Comparisons, how-tos and resources
BPC-157 vs TB-500: Research Comparison
Two of the most discussed recovery and tissue-repair research peptides, side by side. What each compound is, what each is studied for, how their proposed mechanisms differ, and why researchers describe them as complementary in the Wolverine stack. Research use only.
Read the guide →Retatrutide vs Tirzepatide vs Semaglutide | Research
A research-framed comparison of three GLP-class peptides by what they actually act on at the receptor level (single, dual and triple agonism) and where each one currently sits in the clinical-trial and approval pipeline. No outcome promises, no dosing, no medical advice.
Read the guide →GLOW Peptide Blend: The Complete Research Guide
A research-framed guide to the GLOW blend: what the 70mg combination of GHK-Cu, BPC-157 and TB-500 is, what each component is studied for, why the three are paired, and how to verify the batch through an independent Novagen Certificate of Analysis.
Read the guide →Bacteriostatic Water for Peptides: The Research Guide
What bacteriostatic water is, why it is the established diluent for reconstituting lyophilised research peptides, and how it differs from sterile water and saline. Written for a research-use-only context.
Read the guide →How to Reconstitute Peptides: Research Lab Guide
A clear, ordered laboratory procedure for reconstituting a lyophilised research peptide with bacteriostatic water, plus the concentration and U-100 unit maths. Research use only, not a human-use protocol.
Read the guide →What Is a Research Peptide? Honest AU Guide
A plain, honest definition of the research peptide category: what these molecules are, what Research Use Only actually means, and how they sit apart from approved medicines and from supplements. No claims, no hype, just the framing done properly.
Read the guide →How to Read a Peptide Certificate of Analysis (COA)
A plain-English, verify-it-yourself reference for research buyers: what HPLC purity and mass spec identity actually mean, how to authenticate a Novagen report, how to match batch numbers, and the red flags that signal a fabricated certificate.
Read the guide →GHK-Cu vs BPC-157: Research Comparison
Two research peptides that are often confused, set side by side. What each compound is, what each is studied for, how they differ in structure and origin, and why both appear together in the GLOW blend. Research use only.
Read the guide →Wolverine Stack Australia: BPC-157 + TB-500 Research Guide
The Wolverine Stack pairs BPC-157 (10 mg) with TB-500 (5 mg), two widely researched recovery peptides studied for their complementary repair pathways. BPC-157 is investigated in preclinical models for localised tissue, tendon and gut repair plus angiogenesis, while TB-500 is studied for systemic cell migration and flexibility. It is supplied as a complete research kit for laboratory use only.
Read the guide →KLOW Blend: The 4-Peptide GHK-Cu, BPC-157, TB-500, KPV Guide
KLOW is an 80 mg four-peptide research blend combining GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg) in a single vial. It adds KPV, an alpha-MSH fragment researched in relation to inflammatory signalling in gut and skin models, to the three-peptide GLOW blend. Supplied for research use only.
Read the guide →KPV for Gut Health: What the Research Shows
KPV is the smallest active fragment of alpha-MSH, studied in laboratory and animal models for how it interacts with inflammatory signalling in the gut. Here is the evidence, framed honestly: preclinical only, no human trials, and not a treatment for any condition.
Read the guide →Peptide Storage and Shelf Life: A Research Guide
How research peptides are stored and what influences how long they remain stable, from sealed lyophilised vials to reconstituted solutions, covering fridge versus freezer, light and heat protection, and a general state-by-state reference for the lab setting.
Read the guide →Peptide Needles and Syringes: Research Handling Guide
A plain-English reference to the consumables used in a laboratory peptide-reconstitution workflow: what an insulin syringe is, what U-100 actually means, how gauge and length numbers work, the difference between a fixed-needle syringe and a pen needle head, and what arrives in a complete NovaPeptides kit. Written for research handling and measurement, not human-use instructions.
Read the guide →Peptide Pen vs Insulin Needle: Why a Dosing Pen Wins
A peptide pen is a complete, reusable dosing device that holds a reconstituted research peptide and delivers repeatable click doses through a small fresh pen needle. Compared with loose vials and insulin syringes, a pen is drawn up once rather than pierced repeatedly, which may lower contamination and coring risk, help preserve solution integrity, and make each measured dose repeatable. Supplied strictly for research use only.
Read the guide →Retatrutide vs Semaglutide: Research Compared
A neutral, educational summary of how these two incretin-related compounds differ in receptor mechanism, clinical development stage and Australian regulatory status. General information only, not legal or medical advice.
Read the guide →Cagrilintide vs Semaglutide: Research Compared
A side by side look at two metabolic research compounds, one an investigational amylin analogue and one an approved GLP-1 receptor agonist, at the mechanism and trial level. General information only, not legal or medical advice.
Read the guide →Peptide Half-Life Explained (Research Guide)
A plain-language look at what pharmacokinetic half-life means, how researchers measure it, and why the half-life of one peptide can be minutes while another lasts days. General information only, not legal or medical advice.
Read the guide →TGA Peptide Rules in Australia (2026) Explained
How the Therapeutic Goods Administration regulates peptides in Australia: the Poisons Standard, scheduling, the ARTG and what research-use-only means. General information only, not legal or medical advice.
Read the guide →Tirzepatide vs Semaglutide: Research Compared
A neutral, side by side look at how tirzepatide and semaglutide are described in the published literature, covering receptor mechanism, clinical trial programmes and their regulatory status in Australia. This page is written for research and educational context only. General information only, not legal or medical advice.
Read the guide →Retatrutide vs CagriSema: Research Compared
A plain comparison of two of the most closely watched investigational metabolic candidates, focused only on how each is described in the published literature: mechanism of action and clinical trial stage. Both are experimental and neither is an approved consumer product. General information only, not legal or medical advice.
Read the guide →Questions? Talk to us.
Message us on WhatsApp and we will walk you through the kits, the COAs, reconstitution and the dose tool.
Chat with us on WhatsApp